Coeptis Therapeutics signs binding LOI to acquire NexGenAI AI marketing platform

Z Squared Inc.

Binding letter of intent to acquire NexGenAI Affiliates Network, an AI-powered marketing and RPA platform.
Platform targets biotech, pharmaceutical, and multi-level marketing industries for compliance and efficiency.
Closing subject to preparation and execution of definitive documents; no material terms disclosed.
Acquisition expands Coeptis beyond cell therapy into AI-driven marketing software solutions.
CEO Dave Mehalick says integration will drive operational efficiency and growth opportunities.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.